Dr Liz Dallimore is a research & development specialist and Director at KPMG with more than 15 years experience in research, innovation and technology across the UK and Australia, the biotechnology industry being a key focus.
A biomedical scientist by training, Liz commenced her PhD in Neuroscience at the University of Oxford and completed it at The University of Western Australia, supervised by Professor Alan Harvey (Board Director), and worked at the Perron Institute from 2000-2001 in the Stroke Research group. Liz’s previous roles encompassed innovation and R&D at Ernst & Young in Melbourne and PricewaterhouseCoopers in both Melbourne and Perth. Liz completed an MBA (Technology) in 2013 and was awarded an Alumni Prize for top student in capstone courses by the Australian Graduate School of Management. Previously Liz was a judge and mentor for the RMIT University (Melbourne) Business Plan Competition; now in its 16th year it focuses on bringing innovative ideas to market. Liz is currently a WA Committee Member for AusBiotech Perth and a panelist in the Life Sciences Division for the Australian branch of the venture-catalyst Springboard Enterprises.